Trial
NCT05159388
A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody) in Patients With Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Servier Bio-Innovation LLC
Collaborators
Institut de Recherches Internationales Servier
Condition
Solid Tumor
Intervention
PRS-344/S095012
Why stopped
Sponsor decision to terminate during Phase 1
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-16